Stock Market & Financial Investment News

News Breaks February 15, 2013 08:26 EDT AFFY, FMS Affymax stock reaction misplaced, says RW Baird Baird believes yesterday's reaction in shares of Affymax (AFFY) was misplaced in respect to the Fresenius (FMS) pilot program. The firm sees yesterday's communication as standard operating procedure and is actually a strong positive signal suggesting the chances of an expanded contract are now materially higher. Shares are Outperform rated with a $30 price target. News For AFFY;FMS From The Last 14 Days Check below for free stories on AFFY;FMS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 07:22 EDT FMS Citigroup to host a conference Subscribe for More Information June 10, 2013 05:45 EDT FMS Fresenius Medical upgraded to Overweight from Equal Weight at Barclays Subscribe for More Information June 7, 2013 05:29 EDT AFFY Affymax appoints Rich Brenner CEO, terminates CFO, names Mark Thompson CFO Subscribe for More Information 05:24 EDT AFFY Affymax delisted from Nasdaq Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.